Click Here for important COVID-19 information from Alverno Labs

Alverno Laboratories
Clinical Test Bulletins

Dear Healthcare Provider,
The information contained here may be very important to your practice. Please take a moment to review this document.

COVID-19 TESTING UPDATE

Alverno Laboratories will now offer qualitative COVID-19 IgG antibody testing performed by ARUP Laboratories. IgG antibodies are likely to be present in most individuals approximately two weeks after the onset of COVID-19 symptoms. Please see page 2 for details.

PAIN MANAGEMENT PANEL UPDATE

Alverno Laboratories has updated its pain management panel that includes 78 different drugs and metabolites. Please see page 3 to 5 for details.

Fentanyl and Buprenorphine Screening

With Reflex Quantitation

May 19, 2020

Alverno Laboratories will now perform Fentanyl and Buprenorphine screenings in house for a faster TAT. The screening assay will be reflexed for quantitation, if positive. Please see the ordering details on the right.

Soft Codes

FENT
BUPRH

Specimen Requirements

Specimen: Urine, 5mL (min)
Stability: Up to 5 days refrigerated

Method

EIA

Availability

Testing is available 24 hours a day, 7 days a week

CPT

80307* for screening
80348* or 80354* if reflexed for quantitation

Information regarding Soft order codes and CPT codes* can be found on our website, www.AlvernoLabs.com, or by calling 800-937-5521. *CPT codes provided are for informational purposes only. Questions regarding coding should be directed to the payer.

Test Summary

COVID-19 IgG Antibody Testing

April 28, 2020

Alverno Laboratories will now offer qualitative COVID IgG antibody testing performed by ARUP Laboratories. IgG antibodies are likely to be present in most individuals approximately two weeks after the onset of COVID-19 symptoms. If a specimen is collected too early, antibody tests can yield false-negative results. Detection of IgG antibodies can be used to indicate exposure to SARS-CoV2; however, presence of IgG antibodies does not establish definitive immunity to COVID-19.

Individuals may still be infectious for some time after seroconversion occurs and antibodies are detectable. Molecular tests are the only tests currently recommended for the diagnosis of COVID-19 infection, and IgG status should not be used to inform infectious status.

Soft code: COVGA
TAT: 1-5 days
Specimen type: Serum or EDTA plasma
Specimen stability: 1 week refrigerated

Test Summary

Pain Management Panel Update

GO LIVE MAY 5, 2020

Test code: PNMPL (replaces PMUDI, PMUD and PMSRQ)
Sample type: Urine (no change)

Panel includes 78 different drugs and metabolites. See below for the list of included drugs. A current medication list must accompany the specimen for proper interpretation. Additional drugs will not be able to be added to the panel. A window of detection list can be provided by your account representative. Specimens can be sent with an order from your EMR or on a manual requisition. There is no longer a need to send both. Please be sure to include the list of current medications with either format. Requests for testing on saliva will continue to follow the existing process and will be sent to Cordant Laboratories.

Testing will be run on Tuesday and Thursday. Specimens received in the lab by 1:00 p.m. will be set up on these days. Results will be available the following day, Wednesday or Friday. This is subject to change if volumes increase.

To speak to a certifying Technologist or Toxicologist, please call Client Services at 219-989-3700.

Specimen Requirements
Specimen: Urine, 10mL
Stability: Up to 7 days refrigerated
Method: Liquid Chromatography Mass Spectrometry
Availability: Batched; Tuesday and Thursday
CPT: 80307*

Information regarding Soft order codes and CPT codes* can be found on our website, www.AlvernoLabs.com, or by calling 800-937-5521. *CPT codes provided are for informational purposes only. Questions regarding coding should be directed to the payer.